MyoKardia Hires Chief Operating Officer, and VP of Medical Affairs

June Lee is joining MyoKardia (NASDAQ: [[ticker:MYOK]]) to become the South San Francisco-based heart drug developer’s chief operating officer. Lee comes to MyoKardia from the faculty of the University of California, San Francisco. Before joining UCSF, Lee worked in clinical development at Genentech. MyoKardia also named Radhika Tripuraneni the company’s vice president of medical affairs. Most recently, Tripuraneni was vice president of medical affairs at Synageva BioPharma, which was acquired by Alexion Pharmaceuticals (NASDAQ: [[ticker:ALXN]]). She has also held senior management positions at Gilead Sciences (NASDAQ: [[ticker:GILD]]) and Genzyme.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan